Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-03-09 @ 1:57 AM
Study NCT ID:
NCT03169894
Status:
TERMINATED
Last Update Posted:
2024-02-26
First Post:
2017-05-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis
Sponsor:
Avalo Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-14
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-12
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-24
First Submit QC Date:
None
Study First Post Date:
2017-05-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-07
Results First Submit QC Date:
None
Results First Post Date:
2024-02-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-27
Last Update Post Date:
2024-02-26
Last Update Post Date Type:
ACTUAL